Semaglutide

Product Specifications

Form: Lyophilized peptide powder
Strength: Add the product-specific strength
Peptide Length: 31 amino-acid residues
Peptide Classification: Synthetic acylated GLP-1 analog research peptide

Modified Peptide Sequence: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(acylated)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly

Structural Modifications: Aib substitution at position 2, lipid-linked side chain at Lys20, and arginine substitution at position 28

Molecular Formula: C187H291N45O59

Molecular Weight: Approximately 4113.6 g/mol

CAS Number: 910463-68-2

Purity: ≥99%, where confirmed through batch-specific HPLC analysis

Appearance: White to off-white lyophilized powder

Intended Use: Laboratory research and analytical applications only

Research Applications

• Analytical characterization using HPLC, UPLC, and LC-MS workflows
• In vitro evaluation of GLP-1 receptor binding and associated signaling pathways
• Structure-activity analysis of modified incretin-related peptide sequences
• Investigation of peptide stability under controlled enzymatic and buffer conditions
• Evaluation of lipid-linked peptide interactions and protein-association behavior
• Peptide identity, purity, molecular weight, and structural integrity assessment
• Comparative analysis of synthetic GLP-1 analogs in non-clinical research models

Quality Documentation

A batch-specific Certificate of Analysis and applicable analytical documentation should be available for each lot. Peptide identity, modified sequence, purity, molecular weight, formulation details, and batch information should be verified against the records supplied with the individual product.

For Laboratory Research Use Only

This product is intended exclusively for controlled laboratory and in vitro research. Not for human or veterinary use. Not for diagnostic, therapeutic, clinical, cosmetic, or household applications.